Since then, a paracrine circuit involving IL-6, which increases the levels of fibrinogen and thromboplastin thereby causing thrombocytosis, has been found to be associated with increased thrombotic risk in patients with ovarian cancer and other neoplasms. Here, IL6 is linked to neoplasm.